Antiviral responses must be tightly regulated to defend rapidly against infection while minimizing inflammatory damage. Type 1 interferons (IFN-I) are crucial mediators of antiviral responses 1 and their transcription is regulated by a variety of transcription factors 2 ; principal among these is the family of interferon regulatory factors (IRFs) 3 . The IRF gene regulatory networks are complex and contain multiple feedback loops. The tools of systems biology are well suited to elucidate the complex interactions that give rise to precise coordination of the interferon response. Here we have used an unbiased systems approach to predict that a member of the forkhead family of transcription factors, FOXO3, is a negative regulator of a subset of antiviral genes. This prediction was validated using macrophages isolated from Foxo3-null mice. Genome-wide location analysis combined with gene deletion studies identified the Irf7 gene as a critical target of FOXO3. FOXO3 was identified as a negative regulator of Irf7 transcription and we have further demonstrated that FOXO3, IRF7 and IFN-I form a coherent feed-forward regulatory circuit. Our data suggest that the FOXO3-IRF7 regulatory circuit represents a novel mechanism for establishing the requisite set points in the interferon pathway that balances the beneficial effects and deleterious sequelae of the antiviral response.
Systems biology approaches were used to identify the gene regulatory circuits that control the anti-viral response. We combined gene expression analysis with transcription factor binding site motif scanning algorithms to infer a network of associations between transcription factors and target genes that were activated in macrophages by polyinosinic-polycytidylic acid (PIC), a widely used surrogate for double-stranded RNA (dsRNA) viruses that stimulates the interferon response 4 ( Supplementary Fig. 1 and Supplementary Table 1 ). Transcription factor binding site (TFBS) motifs for IRF, STAT and FOXO transcription factors were significantly over-represented within cluster 2, which includes antiviral genes such as Gbp2, Ccl5, Ifit1, Irf7 and Oasl1 ( Supplementary Fig. 2 and Supplementary Tables 1 and 2) . Although all FOXO transcription factors bind a common DNA element 5 , we decided to focus on FOXO3 because it was the sole member of the family that was significantly repressed after PIC stimulation of macrophages ( Supplementary Table 3 ). Interestingly, the repression of Foxo3 transcription was mirrored by increased transcription of Irf5, Irf7, Irf8, Stat1, Stat2, Stat3 and Stat5a genes ( Supplementary Fig. 3 ). This result indicated that FOXO3 might act as a repressor of the IRF and STAT transcription factors, master regulators of the IFN-I pathways.
To investigate the role of FOXO3 in the regulation of the IFN-I pathway we examined the global gene expression profile in macrophages derived from Foxo3-null mice (Fig. 1 ). We detected significantly increased transcription of a subset of interferon-stimulated genes (ISGs) under basal conditions in Foxo3-null macrophages when compared to their wild-type counterparts, indicating that FOXO3 functions as a repressor of these genes (Fig. 1a, b and Supplementary Table 4 ). Stimulation of Foxo3-null macrophages with PIC further increased the levels of this subset of ISGs (Fig. 1c, d and Supplementary Table 5 ), and also revealed the transcription of additional ISGs (Fig. 1c, d and Supplementary Tables 4 and 5 ). The induction of these ISGs was validated by quantitative PCR with reverse transcription (RT-PCR; Fig. 1e ). Importantly, Ifnb1 itself was super-induced in PIC-stimulated macrophages from Foxo3-null mice (Fig. 1c , e and Supplementary Fig.  4b ), indicating the possibility that the additional subset of ISGs were regulated by autocrine feedback. To distinguish whether the enhanced expression of ISGs in Foxo3-null macrophages was due to direct effects of the transcription factor or due to autocrine effects of the cytokine, we performed genome-wide chromatin immunoprecipitation/DNA sequencing (ChIP-Seq) analysis in unstimulated macrophages as well as in macrophages stimulated by PIC. Direct FOXO3 target genes included Cmpk2, Ddx58, Ifih1, Irf7, Mx2 and Rsad2, all of which have antiviral functions 1,6 ( Fig. 2a , b, Supplementary Fig. 5 and Supplementary Table 6 ).
The Irf7 gene was of particular interest because of its critical role in the establishment of the antiviral response 7 , and we therefore examined the relationship between it and FOXO3 in more detail. Quantitative RT-PCR demonstrated that basal levels of Irf7 messenger RNA from Foxo3-null macrophages were 5.5-fold higher than those in wild-type cells, whereas PIC-induced Irf7 mRNA levels were similar in wild-type and Foxo3-null cells (Fig. 1e ). These results were validated by western blot analysis ( Supplementary Fig. 4a ). Furthermore, deletion of FOXO3 TFBS in the Irf7 gene promoter resulted in an increased basal Irf7 promoter activity, and thus recapitulated the phenotype of Foxo3-null macrophages ( Supplementary Fig. 6 ). These results indicate that FOXO3 functions as a negative regulator of basal Irf7 transcription.
In order to identify the mechanism by which FOXO3 suppresses the transcription of Irf7, we quantified histone acetylation, ubiquitination and methylation at the Irf7 gene promoter in wild-type and Foxo3-null macrophages ( Fig. 2c ). Histone acetylation was significantly increased in Foxo3-null macrophages, suggesting an epigenetic mechanism for FOXO3-mediated repression of the Irf7 gene ( Fig. 2c, d ). It is worth noting that enhanced histone acetylation correlates with increased transcription of the Irf7 gene in activated macrophages (Supplementary Fig. 7 ). Histone acetylation is associated with an open chromatin structure that allows access of transcription factors to the DNA 8 ; decreased acetylation results in the chromatin closing thereby impeding the binding of transcription factors to the promoter. A protein-protein interaction map 9 predicted 8 histone deacetylases that might mediate this effect (data not shown), and direct biochemical approaches including co-immunoprecipitation and ChIP-ReChIP demonstrated the existence of a ternary complex consisting of FOXO3, nuclear co-repressor 2 (NCOR2) and histone deacetylase 3 (HDAC3) on the Irf7 promoter ( Fig. 2e and Supplementary Fig. 8 ). A functional role for this complex is supported by the observation that treatment of macrophages with HDAC inhibitors, valproic acid (VPA) and apicidin 10 , results in increased levels of Irf7 mRNA (Supplementary Fig. 9 ). Most importantly, the binding of NCOR2 and HDAC3 to the Irf7 promoter was significantly reduced in Foxo3-null macrophages ( Fig. 2f ).
To ascertain the transcriptional circuitry underlying the regulation of the Irf7 gene we needed to identify all of the participating transcription factors. Motif scanning of the Irf7 gene promoter predicted STAT, IRF and FOXO binding sites (Supplementary Table 7 ). The potential presence of the IRF site raised the possibility of auto-regulation of the Irf7 gene by IRF7 itself, a contention supported by previous overexpression studies 11 . ChIP analysis validated the prediction that IRF7 binds to its own promoter ( Fig. 2f ), and importantly, FOXO3 restrained this interaction ( Fig. 2g ). Taken together, these results suggest a model in which a ternary complex of FOXO3, NCOR2 and HDAC3 facilitates a closed chromatin structure and limits IRF7 auto-regulation in macrophages under basal conditions ( Fig. 2h ).
If the FOXO3, NCOR2 and HDAC3 ternary complex keeps basal transcription of Irf7 in check, how then does PIC-stimulation overcome this inhibition? We have observed that PIC-stimulation of macrophages results in the clearance of FOXO3, NCOR2 and HDAC3 from the Irf7 promoter, and that this clearance is temporally associated with PIC-induced Ifnb1 production ( Fig. 2b and Supplementary Figs 8b and 10 ). The most plausible hypothesis is that PIC-stimulated IFN production regulates the association of FOXO3 with the Irf7 promoter. This hypothesis was confirmed by the observation that stimulation of macrophages with IFN-b induced the phosphorylation of FOXO3, and this was accompanied by a decrease in Foxo3 mRNA and protein levels (Fig. 3a, b and Supplementary Fig.  10a ). Furthermore, PIC-dependent repression of Foxo3 mRNA and protein levels did not occur in macrophages isolated from IFN-I receptor (IFNAR1)-null mice ( Fig. 3a and Supplementary Fig. 10b ). The decrease in mRNA levels is explained by the observation that FOXO3 is required for its own transcription ( Supplementary Fig. 11 ). The decrease in protein levels can be explained as follows. It has been shown previously that the serine-threonine kinase AKT phosphorylates FOXO3, leading to its translocation from the nucleus and its degradation in the cytosol 12, 13 . We show here that stimulation of macrophages with IFN-b induced the phosphorylation of AKT that was accompanied by phosphorylation of FOXO3 at the Thr 32 residue, a known AKT phosphorylation site (Fig. 3b ). Furthermore, treatment of the cells with AKT inhibitor IV abrogated IFN-I-dependent AKT and FOXO3 phosphorylation and prevented IFN-I-mediated decrease in Foxo3 mRNA and protein levels (Fig. 3b, c and Supplementary Fig.  10c ). Taken together, these results indicate that IFN-I activates the PI3K/AKT pathway, which in turn leads to FOXO3 degradation and to the cessation of Foxo3 transcription.
FOXO3 has been shown to control CTLA-4-mediated regulation of IL-6, TNF-a, MCP-1 and IFN-c in dendritic cells [14] [15] [16] , and this was proposed to occur via increased transcription of superoxide dismutase (SOD2) 15 . This mechanism does not seem to function in FOXO3mediated repression of antiviral responses in macrophages because no differences in Sod2 mRNA levels in Foxo3-null macrophages were 
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detected (data not shown). Taken together, the data indicate that FOXO3 acts in a coherent feed-forward loop, thereby modulating the antiviral response ( Fig. 3d ). Under basal conditions FOXO3 activity serves to limit Irf7 expression (1). IFN-I induces the transcription of Irf7 (ref. 17); this represents the direct, rapid, arm of the feedforward motif (2). Concomitantly, IFN-I inhibits the transcription of Foxo3 (3), which leads to the depletion of FOXO3 and alleviates the repression of Irf7. This represents the indirect, slow, arm of the feedforward motif. Thus, activation of both arms of the feed-forward motif is required to achieve the high level of IRF7 that is essential for the maximal antiviral response. In addition, this feed-forward pathway is aided by positive feedback regulation of IRF7 on IFN-I (4) ( Supplementary Fig. 12 ), and by positive auto-regulation of IRF7 (5) . By limiting the transcription of Irf7, FOXO3 prevents leakiness (2)
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of IRF7-induced genes in the absence of a viral infection. In addition, FOXO3 prevents spurious noise in the activity of IFN-I because it is capable of dampening the IRF7-induced positive feedback on IFN-I production.
A fine balance exists between optimal immune clearance of a virus and the collateral damage that is inflicted on infected tissue during the host response. The FOXO3-IRF7 regulatory circuit represents an ideal mechanism for balancing host defence with inflammatory damage. Since we discovered and explored the FOXO3-IRF7 regulatory circuit in macrophages we needed an in vivo model system in which macrophages are the principal cells that produce IFN-I in a viral infection. The vesicular stomatitis virus (VSV) lung infection model fully meets this criterion since it has been shown that alveolar macrophages are the primary interferon producers to intranasal infection, and that this response is cell-intrinsic because depletion of alveolar macrophages completely ablates host defence to the virus 18 . Furthermore, VSV is an RNA virus 19 which triggers similar pathways to PIC and which is controlled in an IRF7-dependent manner 7 . Intranasal infection of wild-type mice resulted in a low-grade inflammatory response by day two following infection that was accompanied by intermediate viral load (Fig. 4a-c) . By day five the inflammatory response had resolved and viral titres were at basal levels (Fig. 4a-c) . By contrast, Foxo3-null mice had significantly decreased viral loads at day two when compared with wild-type mice (Fig. 4b, c) ; however, this response was accompanied by significant lung pathology, including pronounced neutrophil influx, haemorrhage and tissue damage ( Fig. 4a and Supplementary Fig. 13 ). The virus was cleared by day five and lung inflammation was mostly resolved (Fig. 4a-c) . Finally, viral replication was not controlled in Irf7-null mice (Fig. 4b, c ). By day five these mice had developed severe pulmonary oedema and were killed (Fig. 4a ).
As discussed above, we chose the VSV model system because the anti-viral response is intrinsic to alveolar macrophages 18 . Consistent with this, we demonstrated that alveolar macrophages, isolated from VSV-infected Foxo3-null animals, expressed considerably greater levels of mRNA encoding Irf7, Ifnb1 and other inflammatory cytokines including Ccl5, Ccl7 and Ccl12 than their wild-type counterparts ( Supplementary Fig. 14 and data not shown) . The increased basal levels of Irf7 mRNA in Foxo3-null alveolar macrophages further support a cell-intrinsic role for FOXO3, although it is formally possible that other targets are also involved. A recent study demonstrated a cellintrinsic increase in CD8 T-cell expansion in Foxo3-null mice 20 . We detected comparable T-cell numbers in the lungs of VSV-infected wild-type and Foxo3-null mice, indicating that T cells are not contributing to the phenotype (data not shown). The data presented above is consistent with the proposed role of the FOXO3-IRF7 circuit in host defence against viruses. The model predicts that FOXO3 suppresses the IRF7-dependent antiviral response to curb the collateral damage associated with host defence. We argue that the dynamic interplay between FOXO3, IRF7 and IFN-I optimizes the antiviral response to achieve the appropriate balance between host defence and rampant inflammation.
METHODS SUMMARY
Cell culture. Bone marrow macrophages (BMMs) were isolated from C57BL/6, Foxo3 2/2 , Irf7 2/2 and Ifnar1 2/2 mice, essentially as described 21 . BMMs collected from femurs were plated on non-tissue-culture-treated plastic in complete RPMI medium containing 10% (v/v) FBS (Hyclone Laboratories), 2 mM L-glutamine, 100 IU ml 21 of penicillin and 100 g ml 21 of streptomycin (all from Cellgro, Mediatech) and supplemented with recombinant human macrophage colonystimulating factor (50 ng ml 21 ; Peprotech). BMMs were treated for various length of time with high-purity LPS (10 ng ml 21 ; Salmonella minnesota; List Biologicals), Pam 3 CSK 4 (300 ng ml 21 ; EMC Microcollections), PIC (6 mg ml 21 ; Amersham), purified murine IFN-b (1.45 3 10 29 U ml 21 ; PBL-interferon source), VPA (5 mM; Sigma), Apicidin (2.5 mM; Sigma), Ly294002 (50 mM; Sigma) and AKT inhibitor IV (20 mM; EMD Chemicals). Microarrays and quantitative RT-PCR. RNA isolation for transcriptome analysis of BMMs was performed using TRIzol reagent (Invitrogen). Gene expression profiling was performed using Affymetrix GeneChip Mouse Genome 430 2.0 and GeneChip Mouse Exon 1.0 ST arrays. Details of the analytical methods are provided in the Methods. For quantitative RT-PCR, total RNA was reverse-transcribed to complementary DNA and amplified using primers specific for murine transcripts. Expression values were calculated relative to the Eef1a1 mRNA transcripts. ChIP-Seq and ChIP. For ChIP-Seq, immunoprecipitated DNA samples were sequenced on a Illumina HiSeq 2000 sequencing system and aligned using the ELAND software package (Illumina). Peaks identification was performed according to standard methods and is described in full in Methods. For quantitative ChIP, immunoprecipitated DNA samples were amplified with target promoter-specific primers. 
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